Schumer Key To Fate Of PhRMA-Backed Part D Measure

By John Wilkerson / September 23, 2018 at 10:59 PM
Senate Minority Leader Chuck Schumer (D-NY) is the key lawmaker in brand drug makers’ play to get Congress to lower their share of seniors’ drug costs, sources on both sides of the lobbying effort say. House Democrats and Sen. Ron Wyden (D-OR) are trying to block brand drug makers from being handed a win on Part D changes, and House Minority Leader Nancy Pelosi (D-CA) insists that brands agree to additional measures that ban pay-for-delay, add a Medicare Part B...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.